Pulmonx (NASDAQ:LUNG – Get Free Report) posted its earnings results on Monday. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.45) by $0.06, Briefing.com reports. The firm had revenue of $17.67 million for the quarter, compared to analysts’ expectations of $16.67 million. Pulmonx had a negative return on equity of […]
Operator: Thank you for standing by. Welcome to the Pulmonx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
Pulmonx to Participate at Upcoming Investor Conferences tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.